International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.4980
+0.0480 (10.67%)
At close: Aug 21, 2026
International Stem Cell Revenue
International Stem Cell had revenue of $2.68M in the quarter ending June 30, 2026, with 9.32% growth. This brings the company's revenue in the last twelve months to $9.51M, up 3.40% year-over-year. In the year 2025, International Stem Cell had annual revenue of $9.10M with 0.17% growth.
Revenue (ttm)
9.51M
Revenue Growth
+3.40%
P/S Ratio
0.42
Revenue / Employee
288.30K
Employees
33
Market Cap
3.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.10M | 15.00K | 0.17% |
| Dec 31, 2024 | 9.09M | 1.30M | 16.64% |
| Dec 31, 2023 | 7.79M | -391.00K | -4.78% |
| Dec 31, 2022 | 8.18M | 1.00M | 13.99% |
| Dec 31, 2021 | 7.18M | 48.00K | 0.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| CASI Pharmaceuticals | 20.11M |
| Pacific Software | 2.40M |
| TRON Group | 1.01M |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| America Great Health | 363.33K |
| Eastgate Biotech | 137.64K |
| Enzolytics | 46.59K |
International Stem Cell News
- 1 year ago - International Stem Cell reports FY24 EPS (3c) vs. (2c) last year - TheFly
- 1 year ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 3 years ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 4 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire